Clinical trials
Phase 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Terminated | 4 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 10 |
| Children's Oncology Group | 3 |
| Therapeutic Advances in Childhood Leukemia Consortium | 3 |
| NCIC Clinical Trials Group | 2 |
| University Health Network, Toronto | 2 |
| AbbVie | 1 |
| Amgen | 1 |
| Ascentage Pharma Group Inc. | 1 |
| Epizyme, Inc. | 1 |
| Jazz Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 33 |
| Burkitt Lymphoma | 12 |
| Leukemia | 12 |
| Recurrence | 12 |
| Leukemia, Myeloid, Acute | 11 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 10 |
| Lymphoma, Non-Hodgkin | 9 |
| Blast Crisis | 8 |
| Lymphoma, Large B-Cell, Diffuse | 8 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 7 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.